Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC: EORTC 22113-08113 LungTech phase II trial results

Introduction - The international phase II single-arm LungTech trial 22113-08113 of the European Organization for Research and Treatment of Cancer assessed the safety and efficacy of stereotactic body radiotherapy (SBRT) in patients with centrally located early-stage NSCLC. - Methods - Patients with...

Full description

Saved in:
Bibliographic Details
Main Authors: Levy, Antonin (Author) , Adebahr, Sonja (Author) , Hurkmans, Coen (Author) , Ahmed, Merina (Author) , Ahmad, Shahreen (Author) , Guckenberger, Matthias (Author) , Geets, Xavier (Author) , Lievens, Yolande (Author) , Lambrecht, Maarten (Author) , Pourel, Nicolas (Author) , Lewitzki, Victor (Author) , Konopa, Krzysztof (Author) , Franks, Kevin (Author) , Dziadziuszko, Rafal (Author) , McDonald, Fiona (Author) , Fortpied, Catherine (Author) , Clementel, Enrico (Author) , Fournier, Béatrice (Author) , Rizzo, Stefania (Author) , Fink, Christian (Author) , Riesterer, Oliver (Author) , Peulen, Heike (Author) , Andratschke, Nicolaus (Author) , McWilliam, Alan (Author) , Gkika, Eleni (Author) , Schimek-Jasch, Tanja (Author) , Grosu, Anca-Ligia (Author) , Le Pechoux, Cécile (Author) , Faivre-Finn, Corinne (Author) , Nestle, Ursula (Author)
Format: Article (Journal)
Language:English
Published: September 2024
In: Journal of thoracic oncology
Year: 2024, Volume: 19, Issue: 9, Pages: 1297-1309
ISSN:1556-1380
DOI:10.1016/j.jtho.2024.05.366
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jtho.2024.05.366
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S155608642400577X
Get full text
Author Notes:Antonin Levy, MD, PhD, Sonja Adebahr, MD, Coen Hurkmans, PhD, Merina Ahmed, MD, Shahreen Ahmad, MD, Matthias Guckenberger, MD, Xavier Geets, MD, PhD, Yolande Lievens, MD, PhD, Maarten Lambrecht, MD, PhD, Nicolas Pourel, MD, Victor Lewitzki, MD, Krzysztof Konopa, MD, PhD, Kevin Franks, MD, Rafal Dziadziuszko, MD, PhD, Fiona McDonald, MD, PhD, Catherine Fortpied, MSc, Enrico Clementel, MSc, Béatrice Fournier, PhD, Stefania Rizzo, MD, PhD, Christian Fink, MD, Oliver Riesterer, MD, Heike Peulen, MD, PhD, Nicolaus Andratschke, MD, Alan McWilliam, PhD, Eleni Gkika, MD, Tanja Schimek-Jasch, MD, Anca-Ligia Grosu, MD, PhD, Cécile Le Pechoux, MD, Corinne Faivre-Finn, MD, PhD, Ursula Nestle, MD, PhD

MARC

LEADER 00000caa a2200000 c 4500
001 1907187588
003 DE-627
005 20241220171138.0
007 cr uuu---uuuuu
008 241030s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jtho.2024.05.366  |2 doi 
035 |a (DE-627)1907187588 
035 |a (DE-599)KXP1907187588 
035 |a (OCoLC)1475635561 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Levy, Antonin  |e VerfasserIn  |0 (DE-588)1346592373  |0 (DE-627)1907188886  |4 aut 
245 1 0 |a Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC  |b EORTC 22113-08113 LungTech phase II trial results  |c Antonin Levy, MD, PhD, Sonja Adebahr, MD, Coen Hurkmans, PhD, Merina Ahmed, MD, Shahreen Ahmad, MD, Matthias Guckenberger, MD, Xavier Geets, MD, PhD, Yolande Lievens, MD, PhD, Maarten Lambrecht, MD, PhD, Nicolas Pourel, MD, Victor Lewitzki, MD, Krzysztof Konopa, MD, PhD, Kevin Franks, MD, Rafal Dziadziuszko, MD, PhD, Fiona McDonald, MD, PhD, Catherine Fortpied, MSc, Enrico Clementel, MSc, Béatrice Fournier, PhD, Stefania Rizzo, MD, PhD, Christian Fink, MD, Oliver Riesterer, MD, Heike Peulen, MD, PhD, Nicolaus Andratschke, MD, Alan McWilliam, PhD, Eleni Gkika, MD, Tanja Schimek-Jasch, MD, Anca-Ligia Grosu, MD, PhD, Cécile Le Pechoux, MD, Corinne Faivre-Finn, MD, PhD, Ursula Nestle, MD, PhD 
264 1 |c September 2024 
300 |b Illustrationen 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 22. Mai 2024, Artikelversion: 4. September 2024 
500 |a Gesehen am 30.10.2024 
520 |a Introduction - The international phase II single-arm LungTech trial 22113-08113 of the European Organization for Research and Treatment of Cancer assessed the safety and efficacy of stereotactic body radiotherapy (SBRT) in patients with centrally located early-stage NSCLC. - Methods - Patients with inoperable non-metastatic central NSCLC (T1-T3 N0 M0, ≤7cm) were included. After prospective central imaging review and radiation therapy quality assurance for any eligible patient, SBRT (8 × 7.5 Gy) was delivered. The primary endpoint was freedom from local progression probability three years after the start of SBRT. - Results - The trial was closed early due to poor accrual related to repeated safety-related pauses in recruitment. Between August 2015 and December 2017, 39 patients from six European countries were included and 31 were treated per protocol and analyzed. Patients were mainly male (58%) with a median age of 75 years. Baseline comorbidities were mainly respiratory (68%) and cardiac (48%). Median tumor size was 2.6 cm (range 1.2-5.5) and most cancers were T1 (51.6%) or T2a (38.7%) N0 M0 and of squamous cell origin (48.4%). Six patients (19.4%) had an ultracentral tumor location. The median follow-up was 3.6 years. The rates of 3-year freedom from local progression and overall survival were 81.5% (90% confidence interval [CI]: 62.7%-91.4%) and 61.1% (90% CI: 44.1%-74.4%), respectively. Cumulative incidence rates of local, regional, and distant progression at three years were 6.7% (90% CI: 1.6%-17.1%), 3.3% (90% CI: 0.4%-12.4%), and 29.8% (90% CI: 16.8%-44.1%), respectively. SBRT-related acute adverse events and late adverse events ≥ G3 were reported in 6.5% (n = 2, including one G5 pneumonitis in a patient with prior interstitial lung disease) and 19.4% (n = 6, including one lethal hemoptysis after a lung biopsy in a patient receiving anticoagulants), respectively. - Conclusions - The LungTech trial suggests that SBRT with 8 × 7.5Gy for central lung tumors in inoperable patients is associated with acceptable local control rates. However, late severe adverse events may occur after completion of treatment. This SBRT regimen is a viable treatment option after a thorough risk-benefit discussion with patients. To minimize potentially fatal toxicity, careful management of dose constraints, and post-SBRT interventions is crucial. 
650 4 |a Lung cancer 
650 4 |a NSCLC 
650 4 |a Stereotactic ablative radiotherapy 
650 4 |a Thoracic oncology 
700 1 |a Adebahr, Sonja  |e VerfasserIn  |4 aut 
700 1 |a Hurkmans, Coen  |e VerfasserIn  |4 aut 
700 1 |a Ahmed, Merina  |e VerfasserIn  |4 aut 
700 1 |a Ahmad, Shahreen  |e VerfasserIn  |4 aut 
700 1 |a Guckenberger, Matthias  |e VerfasserIn  |4 aut 
700 1 |a Geets, Xavier  |e VerfasserIn  |4 aut 
700 1 |a Lievens, Yolande  |e VerfasserIn  |4 aut 
700 1 |a Lambrecht, Maarten  |e VerfasserIn  |4 aut 
700 1 |a Pourel, Nicolas  |e VerfasserIn  |4 aut 
700 1 |a Lewitzki, Victor  |e VerfasserIn  |4 aut 
700 1 |a Konopa, Krzysztof  |e VerfasserIn  |4 aut 
700 1 |a Franks, Kevin  |e VerfasserIn  |4 aut 
700 1 |a Dziadziuszko, Rafal  |e VerfasserIn  |4 aut 
700 1 |a McDonald, Fiona  |e VerfasserIn  |4 aut 
700 1 |a Fortpied, Catherine  |e VerfasserIn  |4 aut 
700 1 |a Clementel, Enrico  |e VerfasserIn  |4 aut 
700 1 |a Fournier, Béatrice  |e VerfasserIn  |4 aut 
700 1 |a Rizzo, Stefania  |e VerfasserIn  |4 aut 
700 1 |a Fink, Christian  |d 1971-  |e VerfasserIn  |0 (DE-588)121198014  |0 (DE-627)705299767  |0 (DE-576)292581882  |4 aut 
700 1 |a Riesterer, Oliver  |e VerfasserIn  |4 aut 
700 1 |a Peulen, Heike  |e VerfasserIn  |4 aut 
700 1 |a Andratschke, Nicolaus  |e VerfasserIn  |4 aut 
700 1 |a McWilliam, Alan  |e VerfasserIn  |4 aut 
700 1 |a Gkika, Eleni  |e VerfasserIn  |4 aut 
700 1 |a Schimek-Jasch, Tanja  |e VerfasserIn  |4 aut 
700 1 |a Grosu, Anca-Ligia  |e VerfasserIn  |4 aut 
700 1 |a Le Pechoux, Cécile  |e VerfasserIn  |4 aut 
700 1 |a Faivre-Finn, Corinne  |e VerfasserIn  |4 aut 
700 1 |a Nestle, Ursula  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of thoracic oncology  |d Amsterdam : Elsevier, 2006  |g 19(2024), 9, Seite 1297-1309  |h Online-Ressource  |w (DE-627)508331986  |w (DE-600)2223437-8  |w (DE-576)336961553  |x 1556-1380  |7 nnas  |a Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC EORTC 22113-08113 LungTech phase II trial results 
773 1 8 |g volume:19  |g year:2024  |g number:9  |g pages:1297-1309  |g extent:13  |a Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC EORTC 22113-08113 LungTech phase II trial results 
856 4 0 |u https://doi.org/10.1016/j.jtho.2024.05.366  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S155608642400577X  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20241030 
993 |a Article 
994 |a 2024 
998 |g 121198014  |a Fink, Christian  |m 121198014:Fink, Christian  |d 60000  |e 60000PF121198014  |k 0/60000/  |p 20 
999 |a KXP-PPN1907187588  |e 4608418904 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Online verfügbar: 22. Mai 2024, Artikelversion: 4. September 2024","Gesehen am 30.10.2024"],"language":["eng"],"recId":"1907187588","title":[{"title_sort":"Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC","title":"Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC","subtitle":"EORTC 22113-08113 LungTech phase II trial results"}],"person":[{"family":"Levy","given":"Antonin","display":"Levy, Antonin","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Adebahr","given":"Sonja","display":"Adebahr, Sonja","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Coen","family":"Hurkmans","role":"aut","display":"Hurkmans, Coen","roleDisplay":"VerfasserIn"},{"given":"Merina","family":"Ahmed","role":"aut","roleDisplay":"VerfasserIn","display":"Ahmed, Merina"},{"role":"aut","display":"Ahmad, Shahreen","roleDisplay":"VerfasserIn","given":"Shahreen","family":"Ahmad"},{"roleDisplay":"VerfasserIn","display":"Guckenberger, Matthias","role":"aut","family":"Guckenberger","given":"Matthias"},{"given":"Xavier","family":"Geets","role":"aut","roleDisplay":"VerfasserIn","display":"Geets, Xavier"},{"family":"Lievens","given":"Yolande","display":"Lievens, Yolande","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Lambrecht, Maarten","given":"Maarten","family":"Lambrecht"},{"role":"aut","display":"Pourel, Nicolas","roleDisplay":"VerfasserIn","given":"Nicolas","family":"Pourel"},{"given":"Victor","family":"Lewitzki","role":"aut","roleDisplay":"VerfasserIn","display":"Lewitzki, Victor"},{"family":"Konopa","given":"Krzysztof","roleDisplay":"VerfasserIn","display":"Konopa, Krzysztof","role":"aut"},{"role":"aut","display":"Franks, Kevin","roleDisplay":"VerfasserIn","given":"Kevin","family":"Franks"},{"given":"Rafal","family":"Dziadziuszko","role":"aut","roleDisplay":"VerfasserIn","display":"Dziadziuszko, Rafal"},{"roleDisplay":"VerfasserIn","display":"McDonald, Fiona","role":"aut","family":"McDonald","given":"Fiona"},{"role":"aut","display":"Fortpied, Catherine","roleDisplay":"VerfasserIn","given":"Catherine","family":"Fortpied"},{"role":"aut","display":"Clementel, Enrico","roleDisplay":"VerfasserIn","given":"Enrico","family":"Clementel"},{"display":"Fournier, Béatrice","roleDisplay":"VerfasserIn","role":"aut","family":"Fournier","given":"Béatrice"},{"roleDisplay":"VerfasserIn","display":"Rizzo, Stefania","role":"aut","family":"Rizzo","given":"Stefania"},{"roleDisplay":"VerfasserIn","display":"Fink, Christian","role":"aut","family":"Fink","given":"Christian"},{"family":"Riesterer","given":"Oliver","roleDisplay":"VerfasserIn","display":"Riesterer, Oliver","role":"aut"},{"given":"Heike","family":"Peulen","role":"aut","display":"Peulen, Heike","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Andratschke, Nicolaus","role":"aut","family":"Andratschke","given":"Nicolaus"},{"roleDisplay":"VerfasserIn","display":"McWilliam, Alan","role":"aut","family":"McWilliam","given":"Alan"},{"display":"Gkika, Eleni","roleDisplay":"VerfasserIn","role":"aut","family":"Gkika","given":"Eleni"},{"roleDisplay":"VerfasserIn","display":"Schimek-Jasch, Tanja","role":"aut","family":"Schimek-Jasch","given":"Tanja"},{"given":"Anca-Ligia","family":"Grosu","role":"aut","display":"Grosu, Anca-Ligia","roleDisplay":"VerfasserIn"},{"given":"Cécile","family":"Le Pechoux","role":"aut","roleDisplay":"VerfasserIn","display":"Le Pechoux, Cécile"},{"family":"Faivre-Finn","given":"Corinne","display":"Faivre-Finn, Corinne","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Ursula","family":"Nestle","role":"aut","roleDisplay":"VerfasserIn","display":"Nestle, Ursula"}],"physDesc":[{"noteIll":"Illustrationen","extent":"13 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Amsterdam ; Philadelphia, Pa.","dateIssuedDisp":"2006-","dateIssuedKey":"2006","publisher":"Elsevier ; Lippincott Williams & Wilkins"}],"id":{"eki":["508331986"],"zdb":["2223437-8"],"issn":["1556-1380"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC EORTC 22113-08113 LungTech phase II trial resultsJournal of thoracic oncology","recId":"508331986","language":["eng"],"pubHistory":["1.2006 -"],"part":{"extent":"13","volume":"19","text":"19(2024), 9, Seite 1297-1309","pages":"1297-1309","issue":"9","year":"2024"},"titleAlt":[{"title":"JTO"}],"title":[{"title":"Journal of thoracic oncology","subtitle":"JTO ; official publication of the International Association for the Study of Lung Cancer","title_sort":"Journal of thoracic oncology"}]}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"September 2024"}],"id":{"eki":["1907187588"],"doi":["10.1016/j.jtho.2024.05.366"]},"name":{"displayForm":["Antonin Levy, MD, PhD, Sonja Adebahr, MD, Coen Hurkmans, PhD, Merina Ahmed, MD, Shahreen Ahmad, MD, Matthias Guckenberger, MD, Xavier Geets, MD, PhD, Yolande Lievens, MD, PhD, Maarten Lambrecht, MD, PhD, Nicolas Pourel, MD, Victor Lewitzki, MD, Krzysztof Konopa, MD, PhD, Kevin Franks, MD, Rafal Dziadziuszko, MD, PhD, Fiona McDonald, MD, PhD, Catherine Fortpied, MSc, Enrico Clementel, MSc, Béatrice Fournier, PhD, Stefania Rizzo, MD, PhD, Christian Fink, MD, Oliver Riesterer, MD, Heike Peulen, MD, PhD, Nicolaus Andratschke, MD, Alan McWilliam, PhD, Eleni Gkika, MD, Tanja Schimek-Jasch, MD, Anca-Ligia Grosu, MD, PhD, Cécile Le Pechoux, MD, Corinne Faivre-Finn, MD, PhD, Ursula Nestle, MD, PhD"]}} 
SRT |a LEVYANTONISTEREOTACT2024